This Massachusetts Marijuana Biotech is Betting the Farm on One Single Drug

Corbus’ stock popped on the release of topline results from a midstage study involving its lead (and only) clinical drug, anabasum.

When it comes to the markets’ fastest growing industries, investors would have a hard time finding a group of stocks growing quicker than marijuana. According to a report from Marijuana Business Daily, the U.S. legal-weed industry is expected to grow by an aggregate of 300% between 2016 and 2021 to approximately $17 billion. That type of growth is tough to ignore, which is why investors have been flocking in droves to marijuana stocks.

MORE ON THIS TOPIC